Chitosan-carboxymethyl tamarind gum in situ polyelectrolyte complex-based floating capsules of ofloxacin: In vitro-in vivo studies

Abstract

The current research attempted to design and evaluate sustained stomach-specific ofloxacin delivery by single-unit hydrodynamically balanced system (HBS)-based floating capsules. These HBS-based floating capsules of ofloxacin were prepared using two oppositely ionic polymers, namely cationic-natured low molecular mass chitosan (LMMCH) and anionic-natured carboxymethyl tamarind gum (CMTG). FTIR results indicated the in situ formation of a polyelectrolyte complex in-between two oppositely charged polymers (i.e., in-between –NH2 group of the cationic natured LMMCH and –COOH groups of the anionic natured CMTG) and the nonexistence of any drug-polymer interaction(s) within these formulated ofloxacin HBS capsules. All these LMMCH-CMTG ofloxacin HBS capsules exhibited drug content uniformity, a sustained in vitro drug-releasing profile over 10 h. The ofloxacin HBS capsules (formulated with 75 mg LMMCH and 25 mg CMTG), which was selected as best formulation (for further studies), exhibited excellent in vitro floatation behaviour in SGF (pH 1.2) over 6 h without any floating lag-time, whereas the same formulation containing barium sulfate (100 mg) instead of drug demonstrated prolonged stomach-specific gastroretention in an in vivo X-ray imaging study using rabbits. Therefore, these types of HBS floating capsules can be useful for stomach-specific gastroretentive floating delivery of other drugs.